Declining kidney function and comorbid conditions like diabetes, cardiovascular disease, and heart failure significantly drive up healthcare costs, particularly inpatient expenses.
Answers are grounded in this paper and cite their sources.
May inform resource planning for CKD with comorbidities; leaves open targeted strategies to reduce inpatient costs.
Poorer kidney function and the presence of diabetes mellitus, cardiovascular disease, or heart failure drive substantial health care costs and increase the proportion of costs attributable to inpatient care. The large contribution of inpatient costs begins in earlier stages of CKD and escalates as kidney function declines. Additional therapies to reduce CKD incidence, slow CKD progression, and lower hospitalization risk are needed to benefit patients and reduce CKD's economic burden.
No takes yet. Share an insight, caveat, or question.
Nichols et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: